BROOK HOUSE SURGERY — All Prescriptions & Medications — Page 2
Practice Code: J82213 | SOUTHAMPTON, SO16 4NZ
Showing results 51-100 of 514
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Doxazosin mesilate | 589 | 26.2K | £1.2K | -44.9% ▼ |
| Zopiclone | 588 | 14.3K | £579 | +6.2% ▲ |
| Indapamide | 587 | 20.5K | £1.1K | -31.9% ▼ |
| Lamotrigine | 583 | 43.5K | £3.9K | -1.3% vs avg |
| Semaglutide | 552 | 9,715 | £50.5K | +129.2% ▲ |
| Glucose blood testing reagents | 550 | 42.9K | £6.4K | -30.3% ▼ |
| Spironolactone | 548 | 12.9K | £1.7K | +1.6% vs avg |
| Allopurinol | 543 | 23.1K | £581 | -47.3% ▼ |
| Melatonin | 542 | 34.1K | £20.4K | +63.0% ▲ |
| 539 | 80.2K | £2.9K | +13.6% ▲ | |
| Apixaban | 514 | 30.3K | £2.8K | -61.2% ▼ |
| Alendronic acid | 513 | 2,552 | £575 | -31.6% ▼ |
| 512 | 271.1K | £2.3K | -48.0% ▼ | |
| Olanzapine | 510 | 10.7K | £1.2K | +37.7% ▲ |
| Montelukast | 478 | 15.5K | £727 | -30.2% ▼ |
| Alginic acid compound preparations | 475 | 255.4K | £3.3K | -18.9% ▼ |
| Rivaroxaban | 469 | 11.2K | £7.1K | -23.3% ▼ |
| Other health supplement preparations | 469 | 10.8K | £1.3K | +887.4% ▲ |
| Edoxaban | 452 | 9,457 | £15.8K | -35.5% ▼ |
| Vitamin B compound | 438 | 20.1K | £1.2K | +214.4% ▲ |
| Sildenafil (Erectile Dysfunction) | 437 | 2,538 | £370 | -13.3% ▼ |
| Estradiol | 433 | 36.4K | £6.8K | -47.2% ▼ |
| Hydrocortisone | 432 | 15.9K | £3.0K | -3.7% ▼ |
| Atenolol | 431 | 16.6K | £377 | -28.5% ▼ |
| Buprenorphine | 419 | 3,664 | £9.2K | +14.4% ▲ |
| Solifenacin | 412 | 14.0K | £669 | -13.7% ▼ |
| Bendroflumethiazide | 402 | 15.0K | £258 | -48.0% ▼ |
| 401 | 180.5K | £2.9K | +52.0% ▲ | |
| Diazepam | 395 | 13.6K | £282 | -20.7% ▼ |
| Lercanidipine hydrochloride | 393 | 12.1K | £1.3K | -36.4% ▼ |
| Morphine sulfate | 393 | 79.6K | £2.8K | -40.1% ▼ |
| Other emollient preparations | 379 | 205.5K | £2.9K | -36.9% ▼ |
| Mometasone furoate | 373 | 436 | £3.5K | -7.1% ▼ |
| Quinine sulfate | 357 | 8,477 | £1.0K | +23.3% ▲ |
| Nitrofurantoin | 355 | 3,892 | £2.2K | -25.6% ▼ |
| Eplerenone | 353 | 9,252 | £1.1K | +33.1% ▲ |
| Insulin aspart | 350 | 2,830 | £16.8K | -8.1% ▼ |
| Loperamide hydrochloride | 346 | 19.3K | £659 | +48.6% ▲ |
| Desogestrel | 344 | 46.6K | £1.5K | -13.2% ▼ |
| Betamethasone valerate | 342 | 30.6K | £1.7K | -11.2% ▼ |
| Methotrexate | 334 | 4,592 | £10.4K | +2.6% ▲ |
| Insulin glargine | 333 | 2,193 | £17.8K | +17.3% ▲ |
| Duloxetine hydrochloride | 326 | 12.7K | £1.0K | -48.7% ▼ |
| Flucloxacillin sodium | 326 | 13.6K | £697 | -27.5% ▼ |
| Lithium carbonate | 321 | 5,831 | £892 | +153.0% ▲ |
| Ibuprofen | 318 | 34.9K | £1.1K | -37.5% ▼ |
| 317 | 440 | £19.5K | +2.1% ▲ | |
| Famotidine | 316 | 7,672 | £4.7K | -35.2% ▼ |
| Metoclopramide hydrochloride | 306 | 14.0K | £595 | +269.3% ▲ |
| Canagliflozin | 304 | 12.2K | £15.2K | +111.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.